The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AI-based identification of FGFR3 mutation status from routine histology slides of muscle-invasive bladder cancer.
 
Charlie Saillard
Employment - Owkin
Stock and Other Ownership Interests - Owkin
Patents, Royalties, Other Intellectual Property - Owkin
 
Pierre-Antoine Bannier
Employment - Owkin
Stock and Other Ownership Interests - Owkin
 
Philipp Mann
Employment - Owkin
Stock and Other Ownership Interests - Owkin
 
Charles Maussion
Employment - Owkin
Stock and Other Ownership Interests - Owkin
Patents, Royalties, Other Intellectual Property - Owkin
 
Christian Matek
No Relationships to Disclose
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; BMS; Boehringer Ingelheim; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; Owkin; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Gilead Sciences; Janssen-Cilag; MSD Oncology; Owkin
Speakers' Bureau - Astellas Pharma; AstraZeneca; Diaceutics; MSD; Roche
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Gilead Sciences; Janssen; Owkin; STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; MSD; Roche